Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia

Pfizer Inc announced today that a significantly higher proportion of patients with newly diagnosed chronic myeloid leukemia who were treated with bosutinib (39 percent) experienced a major molecular response (MMR), a secondary endpoint, compared with... Read More

U.S. scientists took a key step toward controlled nuclear fusion

U.S. scientists have crossed a key step toward controlled nuclear fusion, atomic process that could result in an inexhaustible source of clean energy and solve problems around fossil fuels and emission of greenhouse gases. The researchers managed to... Read More